Extension of the Polyanionic Cosalane Pharmacophore as a Strategy for Increasing Anti-HIV Potency
- 28 April 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (10) , 1767-1777
- https://doi.org/10.1021/jm980727m
Abstract
The anti-HIV agent cosalane inhibits both the binding of gp120 to CD4 as well as an undefined postattachment event prior to reverse transcription. Several cosalane analogues having an extended polyanionic "pharmacophore" were designed based on a hypothetical model of the binding of cosalane to CD4. The analogues were synthesized, and a number of them displayed anti-HIV activity. One of the new analogues was found to possess enhanced potency as an anti-HIV agent relative to cosalane itself. Although the new analogues inhibited both HIV-1 and HIV-2, they were more potent as inhibitors of HIV-1 than HIV-2. Mechanism of action studies indicated that the most potent of the new analogues inhibited fusion of the viral envelope with the cell membrane at lower concentrations than it inhibited attachment, suggesting inhibition of fusion as the primary mechanism of action.status: publisheKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interactionBioorganic & Medicinal Chemistry Letters, 1996
- Correlation of Anti-HIV Potency with Lipophilicity in a Series of Cosalane Analogs Having Normal Alkenyl and Phosphodiester Chains as Cholestane ReplacementsJournal of Medicinal Chemistry, 1996
- Design and synthesis of cosalane, a novel anti-HIV agentBioorganic & Medicinal Chemistry Letters, 1993
- Compounds from Danshen. Part 7. Regioselective introduction of carbon-3 substituents to 5-alkyl-7-methoxy-2-phenylbenzo[b]furans: synthesis of a novel adenosine A1 receptor ligand and its derivativesThe Journal of Organic Chemistry, 1992
- The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.The Journal of Experimental Medicine, 1992
- Synthesis of the covalent hydrate of the incorrectly assumed structure of aurintricarboxylic acid (ATA)Tetrahedron, 1990
- Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication invitroBiochemical and Biophysical Research Communications, 1988
- Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compoundsJournal of Virological Methods, 1988
- Aurintricarboxylic acid and evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virusBiochemical and Biophysical Research Communications, 1986